We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Technology for Studying Membrane Structure

By Biotechdaily staff writers
Posted on 20 Aug 2002
New technology called Aviv Plasmon Waveguide Resonance (PWR) allows researchers to study molecular interactions, protein structure changes, and molecular orientation in membrane environments. More...
The technology was presented at the Protein Society Symposium and Exhibit in San Diego, CA (USA).

Based on the principles of both surface plasmon resonance (SPR) and waveguide phenomena, the Aviv PWR technology is a spectroscopic technique designed to provide critical information about biologic samples in real-time, faster, more directly, and with higher sensitivity than other techniques. Instead of making relative measurements of the resonance angle, the Aviv PWR measures the absolute reflectance as a function of the absolute angle, resulting in reflectance spectra that can be analyzed in terms of the sample's optical properties.

The Aviv PWR technology was developed by Protein Solutions (Lakewood, NJ, USA). Applications currently available include studying membrane-bound proteins and peptides, studying interactions and structure, and characterizing lipid layers. The technology has been applied to the study of G-protein-coupled receptors (GCPRs), a class of membrane proteins involved in cell signaling and regulation. Protein Solutions is licensing the PWR technology on an application-specific basis, with each licensee having exclusive application protection.




Related Links:
Protein Solutions

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Manual Pipetting Aid
Pipette Controllers macro
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.